Hexagon Nutrition IPOÂ Review: GMP, Financials, Valuation & Listing Outlook
Hexagon Nutrition operates in the fast-growing nutrition, wellness and clinical healthcare segment, benefiting from increasing health awareness, preventive healthcare spending and rising demand for specialized nutrition products globally.
The company has built a diversified portfolio of branded nutrition products, strong in-house R&D capabilities and an export presence across more than 75 countries. Its established brands, manufacturing infrastructure and omnichannel distribution network provide a solid platform for future growth.
Financial performance has improved meaningfully over the last few years. Profit after tax increased from Rs. 5.82 crore in FY2023 to Rs. 24.38 crore in FY2025, while margins and return ratios have also strengthened. The balance sheet remains comfortable with low debt and healthy net worth growth.
At the upper price band of Rs. 45, the IPO is valued at a post-issue P/E of around 15.35x, which appears reasonable considering the company’s improving profitability, export diversification and long-term industry prospects.
The key concern is that the issue is entirely an Offer for Sale (OFS) and no fresh capital will be infused into the business. However, the company already possesses adequate manufacturing infrastructure and the listing is expected to improve visibility, liquidity and corporate profile.
Grey market sentiment is encouraging with GMP around Rs. 12, indicating a potential listing premium of nearly 27% over the issue price. Additionally, the lead manager has delivered several IPOs with healthy listing performances in recent years, which may support investor confidence.
Considering reasonable valuation, improving financials, strong nutrition sector positioning, healthy GMP and favourable listing sentiment, we assign a:
👉 Subscribe for Listing Gains.
👉 Risk-taking investors may also consider holding a portion for medium to long-term wealth creation.
If you wish, Study complete details of this IPO